Orphan Diseases

No matter how rare, complex, or difficult the disease, we will give our full dedication to helping you discover the next revolutionary treatment.
 
Orphan diseases, including rare diseases, are conditions that only affect a small patient population. Many of these diseases are caused by a genetic abnormality, but can also be triggered by infectious or toxic agents, injuries, nutritional deficiencies, and adverse treatment effects. The study of these diseases is often neglected because they have unknown mechanisms of action and very few or no available therapy options; thus there is potential for accelerated approval of drugs designated as orphan drugs.
 
Eurofins Discovery’s team of experts is committed to advancing the science of orphan diseases by providing innovative solutions and new technologies for your orphan drug programs, and we have a proven track record of advancing multiple orphan drugs into the clinic. Our scientists will work with you to understand your target and pathway, determine the best medicinal chemistry strategy for your program, and develop robust custom assays along with our unmatched portfolio of validated, ready-to-use assays.